Mithra Pharmaceuticals S.A. sell nvestor
Start price
30.09.23
/
50%
€1.40
Target price
30.09.24
€1.00
Performance (%)
-21.00%
End price
14.10.23
€1.11
Summary
This prediction ended on 14.10.23 with a price of €1.11. The price of Mithra Pharmaceuticals S.A. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -21.00%. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Mithra Pharmaceuticals S.A. | - | - |
| iShares Core DAX® | 2.831% | 1.236% |
| iShares Nasdaq 100 | 2.918% | 0.640% |
| iShares Nikkei 225® | 2.007% | -2.135% |
| iShares S&P 500 | 2.257% | 0.451% |
According to nvestor what are the pros and cons of Mithra Pharmaceuticals S.A. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Bad rating
Little Investments for future growth
Risky balance sheet
Increased challenges to pay loans and raise capital
Below average Management
Little innovation
Few uniques
Dependend from some customers or products
Sustainability is little important
high free float
Higher risks for its business
Significant cyclical dependencies
Business model of the past or high risk
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
negative Cash Flow expected
Bad culture
Growths slower than the competition
Below average Marketposition
Little known brand
Revenue decline/stagnation expected
Low dividend yield expected
Comments by nvestor for this prediction
In the thread Mithra Pharmaceuticals S.A. diskutieren
In the thread Trading Mithra Pharmaceuticals S.A.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.